Latest filing published 28 Jan 2014 for VIROPHARMA INC, €4.1M.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Thomas F. Doyle: trading record in brief
Thomas F. Doyle discloses dealings in Viropharma Inc to SEC (Form 4). We count 41 filings; the first trade dates from 6 December 2006 and the latest from 24 January 2014.
The open-market side counts 1 purchase for €16k alongside 10 sales for €5.4M. Sales outweigh purchases by €5.4M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 4 share grants and 24 option exercises.
The newest entry dates from 28 January 2014: a transaction of €4.1M, in Viropharma Inc. The most recent open-market purchase was published on 27 February 2009, 6,464 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Thomas F. Doyle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 112,089 shares@ US$50.00Common StockSEC:0001127602-14-003235:0
- 48,878 sharesCommon StockSEC:0001127602-14-003235:1
- 48,878 sharesCommon StockSEC:0001127602-14-003235:2
- 7,503 shares@ US$7.05Common StockSEC:0001127602-14-002542:0
- 5,068 shares@ US$19.73Common StockSEC:0001127602-14-002542:1
- 6,561 shares@ US$15.24Common StockSEC:0001127602-14-002542:2
- 5,001 shares@ US$9.96Common StockSEC:0001127602-14-002542:3
- 5,025 shares@ US$9.99Common StockSEC:0001127602-14-002542:4
- 7,407 shares@ US$13.50Common StockSEC:0001127602-14-002542:5
- 10,000 shares@ US$5.91Common StockSEC:0001127602-14-002542:6
- 13,080 shares@ US$8.86Common StockSEC:0001127602-14-002542:7
- 20,000 shares@ US$3.93Common StockSEC:0001127602-12-009882:0
- 30,000 shares@ US$2.09Common StockSEC:0001127602-12-009882:1
- 100,000 shares@ US$3.55Common StockSEC:0001127602-12-009882:2
- 60,000 shares@ US$3.14Common StockSEC:0001127602-12-009882:3
- 210,000 shares@ US$32.48Common StockSEC:0001127602-12-009882:4
- 10,000 shares@ US$20.16Common StockSEC:0001127602-11-031224:0
- 10,000 shares@ US$23.82Common StockSEC:0001127602-11-031224:1
- 2,091 shares@ US$16.89Common StockSEC:0001127602-10-030765:2
- 5,000 shares@ US$3.94Common StockSEC:0001181431-09-012035:0Canonical exit: 28 May 2009 (T+90)
- 2,000 shares@ US$13.00Common StockSEC:0001181431-06-068514:0
- 2,000 shares@ US$15.10Common StockSEC:0001181431-06-068514:1
- 1,000 shares@ US$13.00Common StockSEC:0001181431-06-068514:2
- 1,000 shares@ US$15.07Common StockSEC:0001181431-06-068514:3
- 500 shares@ US$13.00Common StockSEC:0001181431-06-068514:4
25 of 31 declarations